RESULTS FROM A PHASE 2A, OPEN- LABEL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL COMBINATION THERAPIES CONTAINING VIR-2218, SELGANTOLIMOD, AND NIVOLUMAB FOR THE TREATMENT OF CHRONIC HEPATITIS B
HEPATOLOGY(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要